Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's Disease

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Pająk, Beata ^a,b   Kania, Elzbieta ^a   Orzechowski, Arkadiusz ^a,b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; OXYGEN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL; APOPTOSIS; BRAIN; CHEMISTRY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GLYCOSYLATION; HOMEOSTASIS; HUMAN; METABOLISM; MITOCHONDRION; NERVE CELL; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN TRANSPORT; UNFOLDED PROTEIN RESPONSE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; BRAIN; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GLYCOSYLATION; HOMEOSTASIS; HUMANS; MITOCHONDRIA; NEURONS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; OXYGEN; PHOSPHORYLATION; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; TAU PROTEINS; UNFOLDED PROTEIN RESPONSE;

EID: 84955596519     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1805304     Document Type: Review

References (179)

1. R. L. Nussbaum and C. E. Ellis, "Alzheimers disease and Parkinsons disease, "TheNew England Journal ofMedicine, vol. 348, no. 14, pp. 1356-1364, 2003.
2. A. L. Brunkan and A. M. Goate, "Presenilin function and secretase activity, "The Journal of Neurochemistry, vol. 93, no. 4, pp. 769-792, 2005.
3. V. Crentsil, "The pharmacogenomics of Alzheimers disease, " Ageing Research Reviews, vol. 3, no. 2, pp. 153-169, 2004.
4. D. L. Price and S. S. Sisodia, "Mutant genes in familial Alzheimers disease and transgenic models, " Annual Review of Neuroscience, vol. 21, pp. 479-505, 1998.
5. D. Harman, "Alzheimers disease pathogenesis: role of aging, " Annals of the New York Academy of Sciences, vol. 1067, no. 1, pp. 454-460, 2006.
6. D. J. Selkoe, "Translating cell biology into therapeutic advances in Alzheimers disease, " Nature, vol. 399, pp. A23-A31, 1999.
7. H. Braak and E. Braak, "Neuropathological stageing of Alzheimer-related changes, " Acta Neuropathologica, vol. 82, no. 4, pp. 239-259, 1991.
8. K. Hirai, G. Aliev, A. Nunomara et al. , "Mitochondrial abnormalities in Alzheimers disease, "TheJournal ofNeuroscience, vol. 21, pp. 3017-3023, 2001.
9. U. T. Brunk, C. B. Jones, and R. S. Sohal, "A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis, " Mutation Research/DNAging, vol. 275, no. 3-6, pp. 395-403, 1992.
10. P. A. Stewart, K. Hayakawa, M.-A. Akers, and H. V. Vinters, "A morphometric study of the blood-brain barrier in Alzheimers disease, " Laboratory Investigation, vol. 67, no. 6, pp. 734-742, 1992.
11. J. P. Blass and G. E. Gibson, "The role of oxidative abnormalities in the pathophysiology of Alzheimers disease, " Revue Neurologique, vol. 147, no. 6-7, pp. 513-525, 1991.
12. B. Pająk, E. Kania, and A. Orzechowski, "Nucleofection of rat pheochromocytoma PC-12 cells with human mutated betaamyloid precursor protein gene (APP-sw) leads to reduced reduced viability, autophagy-like process, and increased expression and secretion of beta amyloid, " BioMed Research International, vol. 2015, Article ID 746092, 10 pages, 2015.
13. J. P. Blass, "Cerebrometabolic abnormalities in Alzheimers disease, " Neurological Research, vol. 25, no. 6, pp. 556-566, 2003.
14. A. Eckert, K. Schmitt, and J. Götz, "Mitochondrial dysfunction-The beginning of the end in Alzheimers disease? Separate and synergistic modes of tau and amyloid-β toxicity, " Alzheimers Research &Therapy, vol. 3, article 15, pp. 1-11, 2011.
15. U. Keil, A. Bonert, C. A. Marques et al. , "Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis, " The Journal of Biological Chemistry, vol. 279, no. 48, pp. 50310-50320, 2004.
16. A. M. Swomley and D. A. Butterfield, "Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics, " Archives of Toxicology, vol. 89, no. 10, pp. 1669-1680, 2015.
17. C. Caspersen, N. Wang, J. Yao et al. , "Mitochondrial Aβ: A potential focal point for neuronal metabolic dysfunction in Alzheimers disease, " The FASEB Journal, vol. 19, no. 14, pp. 2040-2041, 2005.
18. G. E. Gibson, K.-F. R. Sheu, and J. P. Blass, "Abnormalities of mitochondrial enzymes in Alzheimer disease, " Journal ofNeural Transmission, vol. 105, no. 8-9, pp. 855-870, 1998.
19. A. Eckert, S. Hauptmann, I. Scherping et al. , "Soluble betaamyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice, " Neurodegenerative Diseases, vol. 5, no. 3-4, pp. 157-159, 2008.
20. A. Eckert, K. L. Schulz, V. Rhein, and J. Götz, "Convergence of amyloid-β and tau pathologies on mitochondria in vivo, " Molecular Neurobiology, vol. 41, no. 2-3, pp. 107-114, 2010.
21. S. Hauptmann, I. Scherping, S. Dröse et al. , "Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice, " Neurobiology of Aging, vol. 30, no. 10, pp. 1574-1586, 2009.
22. M. Manczak, B. S. Park, Y. Jung, and P. H. Reddy, "Differential expression of oxidative phosphorylation genes in patients with Alzheimers disease: implications for early mitochondrial dysfunction and oxidative damage, " NeuroMolecular Medicine, vol. 5, no. 2, pp. 147-162, 2004.
23. M. P. Mattson, M. Gleichmann, and A. Cheng, "Mitochondria in neuroplasticity and neurological disorders, " Neuron, vol. 60, no. 5, pp. 748-766, 2008.
24. P. I. Moreira, M. S. Santos, and C. R. Oliveira, "Alzheimers disease: A lesson frommitochondrial dysfunction, " Antioxidants & Redox Signaling, vol. 9, no. 10, pp. 1621-1630, 2007.
25. P. H. Reddy, "Mitochondrial dysfunction in aging and Alzheimers disease: strategies to protect neurons, " Antioxidants & Redox Signaling, vol. 9, no. 10, pp. 1647-1658, 2007.
26. V. Rhein, G. Baysang, S. Rao et al. , "Amyloid-beta leads to impaired cellular respiration, energy production andmitochondrial electron chain complex activities in human neuroblastoma cells, " Cellular and Molecular Neurobiology, vol. 29, no. 6-7, pp. 1063-1071, 2009.
27. V. Rhein, X. Song, A. Wiesner et al. , "Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimers disease mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 20057-20062, 2009.
28. R. X. Santos, S. C. Correia, X. Wang et al. , "Alzheimers disease: diverse aspects of mitochondrialmalfunctioning, " International Journal of Clinical and Experimental Pathology, vol. 3, no. 6, pp. 570-581, 2010.
29. N. R. Sims, "Energymetabolism, oxidative stress and neuronal degeneration in Alzheimers disease, " Neurodegeneration, vol. 5, no. 4, pp. 435-440, 1996.
30. H. K. Anandatheerthavarada, G. Biswas, M.-A. Robin, and N. G. Avadhani, "Mitochondrial targeting and a novel transmembrane arrest of Alzheimers amyloid precursor protein impairs mitochondrial function in neuronal cells, "The Journal of Cell Biology, vol. 161, no. 1, pp. 41-54, 2003.
31. L. Devi, B. M. Prabhu, D. F. Galati, N. G. Avadhani, and H. K. Anandatheerthavarada, "Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimers disease brain is associated with mitochondrial dysfunction, " The Journal of Neuroscience, vol. 26, no. 35, pp. 9057-9068, 2006.
32. L. Devi and H. K. Anandatheerthavarada, "Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimers and Parkinsons diseases, " Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 11-19, 2010.
33. M. Manczak, T. S. Anekonda, E. Henson, B. S. Park, J. Quinn, and P. H. Reddy, "Mitochondria are a direct site of Aβ accumulation in Alzheimers disease neurons: implications for free radical generation and oxidative damage in disease progression, " Human Molecular Genetics, vol. 15, no. 9, pp. 1437-1449, 2006.
34. P. F. Pavlov, C. H. Petersen, E. Glaser, and M. Ankarcrona, "Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis, " Journal of Cellular and Molecular Medicine, vol. 13, no. 10, pp. 4137-4145, 2009.
35. C. Schmidt, E. Lepsverdize, S. L. Chi et al. , "Amyloid precursor protein and amyloid β-peptide bind to ATP synthase and regulate its activity at the surface of neural cells, " Molecular Psychiatry, vol. 13, no. 10, pp. 953-969, 2008.
36. K. Johar, A. Priya, and M. T. T. Wong-Riley, "Regulation of Na+/K+-ATPase by nuclear respiratory factor 1: implication in the tight coupling of neuronal activity, energy generation, and energy consumption, " The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40381-40390, 2012.
37. J. Astrup, P. M. Sorensen, and H. R. Sorensen, "Oxygen and glucose consumption related to Na+-K+ transport in canine brain, " Stroke, vol. 12, no. 6, pp. 726-730, 1981.
38. M. Erecinska and I. A. Silver, "ATP and brain function, " Journal of Cerebral Blood Flow and Metabolism, vol. 9, no. 1, pp. 2-19, 1989.
39. M. Mata, D. J. Fink, H. Gainer et al. , "Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity, " Journal of Neurochemistry, vol. 34, no. 1, pp. 213-215, 1980.
40. J. Kang, H.-G. Lemaire, A. Unterbeck et al. , "The precursor of Alzheimers disease amyloid A4 protein resembles a cell-surface receptor, " Nature, vol. 325, no. 6106, pp. 733-736, 1987.
41. C. L. Masters and D. J. Selkoe, "Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease, " Cold Spring Harbour Perspectives in Medicine, vol. 2, no. 6, Article ID a006262, 2012.
42. A. Lai, S. S. Sisodia, and I. S. Trowbridge, "Characterization of sorting signals in the beta-Amyloid precursor protein cytoplasmic domain, "The Journal of Biological Chemistry, vol. 270, no. 8, pp. 3565-3573, 1995.
43. A. I. Pĺacido, C. M. F. Pereira, A. I. Duarte et al. , "The role of endoplasmic reticulumin amyloid precursor protein processing and trafficking: implications for Alzheimers disease, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 9, pp. 1444-1453, 2014.
44. C. Kaether, P. Skehel, and C. G. Dotti, "Axonal membrane proteins are transported in distinct carriers: A two-color video microscopy study in cultured hippocampal neurons, "Molecular Biology of the Cell, vol. 11, no. 4, pp. 1213-1224, 2000.
45. A. Kamal, A. Almenar-Queralt, J. F. LeBlanc, E. A. Roberts, and L. S. B. Goldstein, "Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP, " Nature, vol. 414, no. 6864, pp. 643-648, 2001.
46. R. G. Perez, S. Soriano, J. D. Hayes et al. , "Mutagenesis identifies new signals for β-Amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42, " The Journal of Biological Chemistry, vol. 274, no. 27, pp. 18851-18856, 1999.
47. D. G. Cook, M. S. Forman, J. C. Sung et al. , "Alzheimers Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells, " Nature Medicine, vol. 3, no. 9, pp. 1021-1023, 1997.
48. A. S. C. Chyung, B. D. Greenberg, D. G. Cook, R. W. Doms, and V. M.-Y. Lee, "Novel β-secretase cleavage of β-Amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells, " The Journal of Cell Biology, vol. 138, no. 3, pp. 671-680, 1997.
49. R. W.-Y. Choy, Z. Cheng, and R. Schekman, "Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 30, pp. E2077-E2082, 2012.
50. S. A. Small and S. Gandy, "Sorting through the cell biology of Alzheimers disease: intracellular pathways to pathogenesis, " Neuron, vol. 52, no. 1, pp. 15-31, 2006.
51. M. Goedert, "Alzheimers and Parkinsons diseases: The prion concept in relation to assembled Aβ, tau, and synuclein, " Science, vol. 349, no. 6248, 2015.
52. I. Benilova, E. Karran, and B. De Strooper, "The toxic Aβ oligomer and Alzheimers disease: An emperor in need of clothes, " Nature Neuroscience, vol. 15, no. 3, pp. 349-357, 2012.
53. E. H. Corder, A. M. Saunders, W. J. Strittmatter et al. , "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families, " Science, vol. 261, no. 5123, pp. 921-923, 1993.
54. S. Brunholz, S. Sisodia, A. Lorenzo, C. Deyts, S. Kins, and G. Morfini, "Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells, " Experimental Brain Research, vol. 217, no. 3-4, pp. 353-364, 2012.
55. G. Thinakaran and E. H. Koo, "Amyloid precursor protein trafficking, processing, and function, " The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29615-29619, 2008.
56. T. Saitoh, M. Sundsmo, J.-M. Roch et al. , "Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts, " Cell, vol. 58, no. 4, pp. 615-622, 1989.
57. M. P. Mattson, B. Cheng, A. R. Culwell, F. S. Esch, I. Lieberburg, and R. E. Rydel, "Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-Amyloid precursor protein, " Neuron, vol. 10, no. 2, pp. 243-254, 1993.
58. K. J. Lee, C. E. H. Moussa, Y. Lee et al. , "Beta amyloidindependent role of amyloid precursor protein in generation andmaintenance of dendritic spines, " Neuroscience, vol. 169, no. 1, pp. 344-356, 2010.
59. H. Meziane, J.-C. Dodart, C. Mathis et al. , "Memory-enhancing effects of secreted forms of the β-Amyloid precursor protein in normal and amnestic mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 21, pp. 12683-12688, 1998.
60. P. R. Turner, K. OConnor, W. P. Tate, and W. C. Abraham, "Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory, " Progress in Neurobiology, vol. 70, no. 1, pp. 1-32, 2003.
61. D. Beher, L. Hesse, C. L. Masters, and G. Multhaup, "Regulation of Amyloid Protein Precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I, " The Journal of Biological Chemistry, vol. 271, no. 3, pp. 1613-1620, 1996.
62. S. L. Sabo, A. F. Ikin, J. D. Buxbaum, and P. Greengard, "The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo, " The Journal of Neuroscience, vol. 23, no. 13, pp. 5407-5415, 2003.
63. D. H. Small, V. Nurcombe, G. Reed et al. , "A heparin-binding domain in the amyloid protein precursor of Alzheimers disease is involved in the regulation of neurite outgrowth, " The Journal of Neuroscience, vol. 14, no. 4, pp. 2117-2127, 1994.
64. T. G. Williamson, S. S. Mok, A. Henry et al. , "Secreted glypican binds to the amyloid precursor protein of Alzheimers disease (APP) and inhibits APP-induced neurite outgrowth, " The Journal of Biological Chemistry, vol. 271, no. 49, pp. 31215-31221, 1996.
65. T. Ondrejcak, I. Klyubin, N.-W. Hu, A. E. Barry, W. K. Cullen, and M. J. Rowan, "Alzheimers disease amyloid β-protein and synaptic function, " NeuroMolecular Medicine, vol. 12, no. 1, pp. 13-26, 2010.
66. D. Puzzo, L. Privitera, and A. Palmeri, "Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory, " Neurobiology of Aging, vol. 33, no. 7, pp. 1484. e15-1484. e24, 2012.
67. C. M. F. Pereira, "Crosstalk between endoplasmic reticulum stress and protein misfolding in neurodegenerative diseases, " ISRN Cell Biology, vol. 2013, Article ID 256404, 22 pages, 2013.
68. R.-W. Shin, T. C. Saido, M. Maeda, and T. Kitamoto, "Novel secretase cleavage ofAlzheimers amyloid β precursor protein in the endoplasmic reticulumof COS7 cells, " Neuroscience Letters, vol. 376, no. 1, pp. 14-19, 2005.
69. E. A. Schon and E. Area-Gomez, "Mitochondria-Associated ER membranes in Alzheimer disease, " Molecular and Cellular Neuroscience, vol. 55, pp. 26-36, 2013.
70. R. Rizzuto, P. Pinton, W. Carrington et al. , "Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses, " Science, vol. 280, no. 5370, pp. 1763-1766, 1998.
71. S. E. Logue, P. Cleary, S. Saveljeva, and A. Samali, "New directions inER-stress induced cell death, " Apoptosis, vol. 18, no. 5, pp. 537-546, 2013.
72. J. P. Decuypere, K. Welkenhuyzen, T. Luyten et al. , "Ins(1, 4, 5)P3 receptor-mediated BI-1 Ca2+ signaling and autophagy induction are interrelated, " Autophagy, vol. 7, pp. 1472-1489, 2011.
73. K. S. Vetrivel and G. Thinakaran, "Membrane rafts in Alzheimers disease beta-Amyloid production, " Biochimica et Biophysica Acta, vol. 1801, no. 8, pp. 860-867, 2010.
74. H. Urra, E. Dufey, F. Lisbona, D. Rojas-Rivera, and C. Hetz, "When ER stress reaches a dead end, " Biochimica et Biophysica Acta (BBA):Molecular Cell Research, vol. 1833, no. 12, pp. 3507-3517, 2013.
75. G. Li, M. Mongillo, K.-T. Chin et al. , "Role of ERO1-mediated stimulation of inositol 1, 4, 5-Triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis, " The Journal of Cell Biology, vol. 186, no. 6, pp. 783-792, 2009.
76. K. Yamamoto, R. Fujii, Y. Toyofuku et al. , "The KDEL receptor mediates a retrieval mechanism that contributes to quality control at the endoplasmic reticulum, " The EMBO Journal, vol. 20, no. 12, pp. 3082-3091, 2001.
77. T. Katayama, K. Imaizumi, N. Satoet al. , "Presenilin-1mutations downregulate the signalling pathway of the unfolded-protein response, " Nature Cell Biology, vol. 1, no. 8, pp. 479-485, 1999.
78. C. Ballatore, V. M.-Y. Lee, and J. Q. Trojanowski, "Tau-mediated neurodegeneration in Alzheimers disease and related disorders, " Nature Reviews Neuroscience, vol. 8, no. 9, pp. 663-672, 2007.
79. B. Frost, R. L. Jacks, and M. I. Diamond, "Propagation of Tau misfolding from the outside to the inside of a cell, " The Journal of Biological Chemistry, vol. 284, no. 19, pp. 12845-12852, 2009.
80. T. Nonaka, S. T. Watanabe, T. Iwatsubo, and M. Hasegawa, "Seeded aggregation and toxicity of synuclein and tau: cellular models of neurodegenerative diseases, " Journal of Biological Chemistry, vol. 285, no. 45, pp. 34885-34898, 2010.
81. J. F. Crary, J. Q. Trojanowski, J. A. Schneider et al. , "Primary agerelated tauopathy (PART): A common pathology associatedwith human aging, " Acta Neuropathologica, vol. 128, no. 6, pp. 755-766, 2014.
82. C. R. Jack Jr. , D. S. Knopman, W. J. Jagust et al. , "Tracking pathophysiological processes in Alzheimers disease: An updated hypothetical model of dynamic biomarkers, " The Lancet Neurology, vol. 12, no. 2, pp. 207-216, 2013.
83. A. Serrano-Pozo, M. P. Frosch, E. Masliah, and B. T. Hyman, "Neuropathological alterations in Alzheimer disease, " Cold Spring Harbor Perspectives in Medicine, vol. 1, no. 1, pp. 1-23, 2011.
84. E. Ferreiro and C. M. F. Pereira, "Endoplasmic reticulumstress: A new playER in tauopathies, " Journal of Pathology, vol. 226, no. 5, pp. 687-692, 2012.
85. J. J. M. Hoozemans and W. Scheper, "Endoplasmic reticulum: The unfolded protein response is tangled in neurodegeneration, " International Journal of Biochemistry & Cell Biology, vol. 44, no. 8, pp. 1295-1298, 2012.
86. J. J. M. Hoozemans, E. S. van Haastert, D. A. T. Nijholt, A. J. M. Rozemuller, P. Eikelenboom, andW. Scheper, "Theunfolded protein response is activated in pretangle neurons in alzheimers disease hippocampus, " The American Journal of Pathology, vol. 174, no. 4, pp. 1241-1251, 2009.
87. Y.-S. Ho, X. Yang, J. C.-F. Lau et al. , "Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: implication in Alzheimers disease pathogenesis, " Journal of Alzheimers Disease, vol. 28, no. 4, pp. 839-854, 2012.
88. Z.-Q. Fu, Y. Yang, J. Song et al. , "LiCl attenuates thapsigargininduced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro, " Journal of Alzheimers Disease, vol. 21, no. 4, pp. 1107-1117, 2010.
89. B. Schenk, F. Fernandez, and C. J. Waechter, "The ins(die) and out(side) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum, " Glycobiology, vol. 11, pp. 61R-67R, 2001.
90. A. Helenius and M. Aebi, "Intracellular functions of N-linked glycans, " Science, vol. 291, no. 5512, pp. 2364-2369, 2001.
91. J. Hitomi, T. Katayama, Y. Eguchi et al. , "Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death, "The Journal of Cell Biology, vol. 165, no. 3, pp. 347-356, 2004.
92. N. Morishima, K. Nakanishi, H. Takenouchi, T. Shibata, and Y. Yasuhiko, "An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12, " The Journal of Biological Chemistry, vol. 277, no. 37, pp. 34287-34294, 2002.
93. D. Rodriguez, D. Rojas-Rivera, and C. Hetz, "Integrating stress signals at the endoplasmic reticulum: The BCL-2 protein family rheostat, " Biochimica et BiophysicaActa, vol. 1813, no. 4, pp. 564-574, 2011.
94. S. Y. Gilady, M. Bui, E. M. Lynes et al. , "Ero1 requires oxidizing and normoxic conditions to localize to the mitochondriaassociated membrane (MAM), " Cell Stress and Chaperones, vol. 15, no. 5, pp. 619-629, 2010.
95. S. Wang andW. S. El-Deiry, "Cytochrome c: A crosslink between the mitochondria and the endoplasmic reticulum in calciumdependent apoptosis, " Cancer Biology and Therapy, vol. 3, no. 1, pp. 44-46, 2004.
96. I. Tabas and D. Ron, "Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress, " Nature Cell Biology, vol. 13, no. 3, pp. 184-190, 2011.
97. T. Yoneda, K. Imaizumi, K. Oono et al. , "Activation ofCaspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-Associated factor 2-dependent mechanism in response to the ER stress, " The Journal of Biological Chemistry, vol. 276, no. 17, pp. 13935-13940, 2001.
98. A. Ebneth, G. Drewes, E.-M. Mandelkow, and E. Mandelkow, "Phosphorylation of MAP2c andMAP4byMARKkinases leads to the destabilization of microtubules in cells, " CellMotility and the Cytoskeleton, vol. 44, no. 3, pp. 209-224, 1999.
99. J. Götz, L. M. Ittner, M. Fändrich, and N. Schonrock, "Is tau aggregation toxic or protective: A sensible question in the absence of sensitive methods?" Journal of Alzheimers Disease, vol. 14, no. 4, pp. 423-429, 2008.
100. L. M. Ittner, Y. D. Ke, F. Delerue et al. , "Dendritic function of tau mediates amyloid-β toxicity in Alzheimers disease mouse models, " Cell, vol. 142, no. 3, pp. 387-397, 2010.
101. K. Stamer, R. Vogel, E. Thies, E. Mandelkow, and E.-M. Mandelkow, "Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress, " The Journal of Cell Biology, vol. 156, no. 6, pp. 1051-1063, 2002.
102. C. S. Casley, L. Canevari, J. M. Land, J. B. Clark, and M. A. Sharpe, "β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities, " Journal of Neurochemistry, vol. 80, no. 1, pp. 91-100, 2002.
103. C. S. Casley, J. M. Land, M. A. Sharpe, J. B. Clark, M. R. Duchen, and L. Canevari, "β-Amyloid fragment 25-35 causesmitochondrial dysfunction in primary cortical neurons, " Neurobiology of Disease, vol. 10, no. 3, pp. 258-267, 2002.
104. S. Sorbi, E. D. Bird, and J. P. Blass, "Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain, " Annals of Neurology, vol. 13, no. 1, pp. 72-78, 1983.
105. K. Takahashi, T. Niidome, A. Akaike, T. Kihara, and H. Sugimoto, "Amyloid precursor protein promotes endoplasmic reticulum stress-induced cell death via C/EBP homologous proteinmediated pathway, " Journal of Neurochemistry, vol. 109, no. 5, pp. 1324-1337, 2009.
106. D. Kögel, C. G. Concannon, T. Müller et al. , "The APP intracellular domain (AICD) potentiates ER stress-induced apoptosis, " Neurobiology of Aging, vol. 33, no. 9, pp. 2200-2209, 2012.
107. C. A. Hansson Petersen, N. Alikhani, H. Behbahani et al. , "The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13145-13150, 2008.
108. H. K. Anandatheerthavarada, N. B. V. Sepuri, G. Biswas, and N. G. Avadhani, "An unusual TOM20/TOM22 bypass mechanism for the mitochondrial targeting of cytochrome P450 proteins containing n-Terminal chimeric signals, " The Journal of Biological Chemistry, vol. 283, no. 28, pp. 19769-19780, 2008.
109. M.-A. Robin, H. K. Anandatheerthavarada, G. Biswas et al. , "Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-Terminal chimeric signal by cAMPmediated phosphorylation, "TheJournal of Biological Chemistry, vol. 277, no. 43, pp. 40583-40593, 2002.
110. J. Zha, H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer, "Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L), " Cell, vol. 87, no. 4, pp. 619-628, 1996.
111. C. A. Hansson, S. Frykman, and M. R. Farmery, "Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria, " The Journal of Biological Chemistry, vol. 279, pp. 51654-51660, 2004.
112. D. Narendra, A. Tanaka, D.-F. Suen, and R. J. Youle, "Parkin is recruited selectively to impaired mitochondria and promotes their autophagy, "The Journal of Cell Biology, vol. 183, no. 5, pp. 795-803, 2008.
113. A. Nechushtan, C. L. Smith, Y.-T. Hsu, and R. J. Youle, "Conformation of the Bax C-Terminus regulates subcellular location and cell death, " The EMBO Journal, vol. 18, no. 9, pp. 2330-2341, 1999.
114. M. Suzuki, R. J. Youle, andN. Tjandra, "Structure of bax: coregulation of dimer formation and intracellular localization, " Cell, vol. 103, no. 4, pp. 645-654, 2000.
115. B. Y. Sheng, Y. Niu, H. Zhou et al. , "The mitochondrial function was impaired in APP knockout mouse embryo fibroblast cells, " Chinese Science Bulletin, vol. 54, no. 10, pp. 1725-1731, 2009.
116. K. Chandrasekaran, K. Hatanpää, D. R. Brady, J. Stoll, and S. I. Rapoport, "Down regulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex, " Brain Research, vol. 796, no. 1-2, pp. 13-19, 1998.
117. I. Maurer, S. Zierz, and H.-J. Möller, "A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, " Neurobiology of Aging, vol. 21, no. 3, pp. 455-462, 2000.
118. W. D. Parker Jr. , "Cytochrome oxidase deficiency in Alzheimers disease, " Annals of the New York Academy of Sciences, vol. 640, pp. 59-64, 1991.
119. W. D. Parker Jr. , N. J. Mahr, C. M. Filley et al. , "Reduced platelet cytochrome c oxidase activity in Alzheimers disease, " Neurology, vol. 44, no. 6, pp. 1086-1090, 1994.
120. H. K. Anandatheerthavarada and L. Devi, "Mitochondrial translocation of amyloid precursor protein and its cleaved products: relevance to mitochondrial dysfunction in Alzheimers disease, " Reviews in theNeurosciences, vol. 18, no. 5, pp. 343-354, 2007.
121. H.-J. Park, S.-S. Kim, Y.-M. Seong et al. , "β-Amyloid precursor protein is a direct cleavage target of HtrA2 serine protease: implications for the physiological function of HtrA2 in the mitochondria, " The Journal of Biological Chemistry, vol. 281, no. 45, pp. 34277-34287, 2006.
122. X. Wang, B. Su, S. L. Siedlak et al. , "Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation ofmitochondrial fission/fusion proteins, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19318-19323, 2008.
123. D. C. David, S. Hauptmann, I. Scherping et al. , "Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice, " The Journal of Biological Chemistry, vol. 280, no. 25, pp. 23802-23814, 2005.
124. D. C. David, L. M. Ittner, P. Gehrig et al. , "β-Amyloid treatment of two complementary P301L tau-expressing Alzheimers disease models reveals similar deregulated cellular processes, " Proteomics, vol. 6, no. 24, pp. 6566-6577, 2006.
125. S. M. Cardoso, M. T. Proenca, S. Santos, I. Santana, and C. R. Oliveira, "Cytochrome coxidase is decreased in Alzheimers disease platelets, " Neurobiology of Aging, vol. 25, pp. 105-110, 2004.
126. S. J. Kish, C. Bergeron, A. Rajput et al. , "Brain cytochrome oxidase in Alzheimers disease, " Journal of Neurochemistry, vol. 59, no. 2, pp. 776-779, 1992.
127. P. J. Crouch, R. Blake, J. A. Duce et al. , "Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42, " The Journal of Neuroscience, vol. 25, no. 3, pp. 672-679, 2005.
128. H. Du, L. Guo, F. Fang et al. , "Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimers disease, " Nature Medicine, vol. 14, no. 10, pp. 1097-1105, 2008.
129. J. W. Lustbader, M. Cirilli, C. Lin et al. , "ABAD directly links Aβ to mitochondrial toxicity in Alzheimers disease, " Science, vol. 304, no. 5669, pp. 448-452, 2004.
130. D. Sirk, Z. Zhu, J. S. Wadia et al. , "Chronic exposure tosub-lethal beta-Amyloid (Aβ) inhibits the import of nuclear-encoded proteins to mitochondria in differentiated PC12 cells, " Journal of Neurochemistry, vol. 103, no. 5, pp. 1989-2003, 2007.
131. S. Melov, P. A. Adlard, K. Morten et al. , "Mitochondrial oxidative stress causes hyperphosphorylation of tau, " PLoS ONE, vol. 2, no. 6, article e536, 2007.
132. P. Bubber, V. Haroutunian, G. Fisch, J. P. Blass, andG. E. Gibson, "Mitochondrial abnormalities in Alzheimer brain: mechanistic implications, " Annals of Neurology, vol. 57, no. 5, pp. 695-703, 2005.
133. H. Du and S. S. Yan, "Mitochondrial permeability transition pore in Alzheimers disease: cyclophilin D and amyloid beta, " Biochimica et Biophysica Acta (BBA):Molecular Basis of Disease, vol. 1802, no. 1, pp. 198-204, 2010.
134. J. Yao, M. Taylor, F. Davey et al. , "Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimers disease patients and a transgenic Alzheimers disease mouse model, " Molecular and Cellular Neuroscience, vol. 35, no. 2, pp. 377-382, 2007.
135. H. Du, L. Guo, W. Zhang, M. Rydzewska, and S. Yan, "Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model, " Neurobiology of Aging, vol. 32, no. 3, pp. 398-406, 2011.
136. D.-H. Cho, T. Nakamura, J. Fang et al. , "S-nitrosylation of Drp1 mediates β-Amyloid-relatedmitochondrial fission and neuronal injury, " Science, vol. 324, no. 5923, pp. 102-105, 2009.
137. X. Wang, B. Su, H. Fujioka, and X. Zhu, "Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimers disease patients, " American Journal of Pathology, vol. 173, no. 2, pp. 470-482, 2008.
138. P. Ferńandez-Vizarra, A. P. Ferńandez, S. Castro-Blanco et al. , "Intra-And extracellular Aβ and PHF in clinically evaluated cases of Alzheimers disease, " Histology and Histopathology, vol. 19, no. 3, pp. 823-844, 2004.
139. M. Escobar-Henriques and T. Langer, "Mitochondrial shaping cuts, " Biochimica et Biophysica Acta (BBA): Molecular Cell Research, vol. 1763, no. 5-6, pp. 422-429, 2006.
140. A. Neutzner, R. J. Youle, and M. Karbowski, "Outer mitochondrial membrane protein degradation by the proteasome, " Novartis Foundation Symposium, vol. 287, pp. 4-14, 2007.
141. I. V. Kurochkin, "Insulin-degrading enzyme: embarking on amyloid destruction, " Trends in Biochemical Sciences, vol. 26, no. 7, pp. 421-425, 2001.
142. D. J. Selkoe, "Clearing the brains amyloid cobwebs, " Neuron, vol. 32, no. 2, pp. 177-180, 2001.
143. R. E. Tanzi, R. D. Moir, and S. L. Wagner, "Clearance of Alzheimers Aβ peptide: The many roads to perdition, " Neuron, vol. 43, no. 5, pp. 605-608, 2004.
144. A. Falkevall, N. Alikhani, S. Bhushan et al. , "Degradation of the amyloid β-protein by the novel mitochondrial peptidasome, PreP, "The Journal of Biological Chemistry, vol. 281, no. 39, pp. 29096-29104, 2006.
145. K. A. Johnson, S. Bhushan, A. Stahl et al. , "The closed structure of presequence protease PreP forms a unique 10 000 A3 chamber for proteolysis, " The EMBO Journal, vol. 25, no. 9, pp. 1977-1986, 2006.
146. P. Moberg, A. Stah, S. Bhushan et al. , "Characterization of a novel zinc metalloprotease involved in degrading targeting peptides in mitochondria and chloroplasts, " The Plant Journal, vol. 36, no. 5, pp. 616-628, 2003.
147. N. Mzhavia, Y. L. Berman, Y. Qian, L. Yan, and L. A. Devi, "Cloning, expression, and characterization of human metalloprotease 1: A novel member of the pitrilysin family of metalloendoproteases, " DNA and Cell Biology, vol. 18, no. 5, pp. 369-380, 1999.
148. A. Stahl, P. Moberg, J. Ytterberg et al. , "Isolation and identification of a novel mitochondrial metalloprotease (PreP) that degrades targeting presequences in plants, " The Journal of Biological Chemistry, vol. 277, no. 44, pp. 41931-41939, 2002.
149. A. Stahl, S. Nilsson, P. Lundberg et al. , "Two novel targeting peptide degrading proteases, PrePs, in mitochondria and chloroplasts, so similar and still different, " Journal of Molecular Biology, vol. 349, no. 4, pp. 847-860, 2005.
150. M. Challa, S. Malladi, B. J. Pellock et al. , "Drosophila Omi, a mitochondrial-localized IAP antagonist and proapoptotic serine protease, " The EMBO Journal, vol. 26, no. 13, pp. 3144-3156, 2007.
151. H. J. Huttunen, S. Y. Gúenette, C. Peach et al. , "HtrA2 regulates β-Amyloid precursor protein (APP) metabolism through endoplasmic reticulum-Associated degradation, " The Journal of Biological Chemistry, vol. 282, no. 38, pp. 28285-28295, 2007.
152. D. L. Vaux and J. Silke, "Mammalian mitochondrial IAP binding proteins, " Biochemical and Biophysical Research Communications, vol. 304, no. 3, pp. 499-504, 2003.
153. L. Vande Walle, M. Lamkanfi, and P. Vandenabeele, "The mitochondrial serine protease HtrA2/Omi: An overview, " Cell Death and Differentiation, vol. 15, no. 3, pp. 453-460, 2008.
154. H. Plun-Favreau, K. Klupsch, N. Moisoi et al. , "The mitochondrial protease HtrA2 is regulated by Parkinsons diseaseassociated kinase PINK1, " Nature Cell Biology, vol. 9, no. 11, pp. 1243-1252, 2007.
155. D. Harman, "Aging: A theory based on free radical and radiation chemistry, " Journal of Gerontology, vol. 11, no. 3, pp. 298-300, 1956.
156. A. Trifunovic, A. Hansson, A. Wredenberg et al. , "Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 17993-17998, 2005.
157. M. Vermulst, J. H. Bielas, G. C. Kujoth et al. , "Mitochondrial point mutations do not limit the natural lifespan of mice, " Nature Genetics, vol. 39, no. 4, pp. 540-543, 2007.
158. S. E. Schriner, N. J. Linford, G. M. Martin et al. , "Extension of murine life span by overexpression of catalase targeted to mitochondria, " Science, vol. 308, no. 5730, pp. 1909-1911, 2005.
159. J. Liu, D. W. Killilea, and B. N. Ames, "Age-Associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-lipoic acid, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 1876-1881, 2002.
160. A. Navarro, C. Gomez, M.-J. ͆anchez-Pino et al. , "Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 289, no. 5, pp. R1392-R1399, 2005.
161. L.-J. Yan and R. S. Sohal, "Mitochondrial adenine nucleotide translocase ismodified oxidatively during aging, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 12896-12901, 1998.
162. A. Bobba, G. Amadoro, V. A. Petragallo, P. Calissano, and A. Atlante, "Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease, " Biochimica et Biophysica Acta (BBA)-Bioenergetics, vol. 1827, no. 7, pp. 848-860, 2013.
163. I. Parentini, G. Cavallini, A. Donati, Z. Gori, and E. Bergamini, "Accumulation of dolichol in older tissues satisfies the proposed criteria to be qualified a biomarker of aging, " The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 60, no. 1, pp. 39-43, 2005.
164. C. Edlund, M. Söderberg, and K. Kristensson, "Isoprenoids in aging and neurodegeneration, " Neurochemistry International, vol. 25, no. 1, pp. 35-38, 1994.
165. P. Navas, J. M. Villalba, and R. de Cabo, "The importance of plasma membrane coenzyme Q in aging and stress responses, " Mitochondrion, vol. 7, supplement, pp. S34-S40, 2007.
166. H. Kraskiewicz andU. Fitzgerald, "IterfERingwith endoplasmic reticulumstress, " Trends in Pharmacological Sciences, vol. 33, no. 2, pp. 53-63, 2012.
167. A. Ricobaraza, M. Cuadrado-Tejedor, S. Marco, I. Perez-Otaño, and A. García-Osta, "Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease, " Hippocampus, vol. 22, no. 5, pp. 1040-1050, 2012.
168. A. F. Nunes, J. D. Amaral, A. C. Lo et al. , "TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice, "Molecular Neurobiology, vol. 45, no. 3, pp. 440-445, 2012.
169. B. Gong, L.-Y. Zhang, C.-P. Pang, D. S.-C. Lam, and G. H.-F. Yam, "Trimethylamine N-oxide alleviates the severe aggregation and ER stress caused by G98R A-crystallin, " Molecular Vision, vol. 15, pp. 2829-2840, 2009.
170. M. Boyce, K. F. Bryant, C. Jousse et al. , "A selective inhibitor of eIF2 dephosphorylation protects cells from ER stress, " Science, vol. 307, no. 5711, pp. 935-939, 2005.
171. P. Jiang, M. Gan, A. S. Ebrahim, W.-L. Lin, H. L. Melrose, and S.-H. C. Yen, "ER stress response plays an important role in aggregation of-synuclein, " Molecular Neurodegeneration, vol. 5, no. 1, article 56, 2010.
172. D. Y. Lee, K.-S. Lee, H. J. Lee et al. , "ActivationofPERKsignaling attenuates Aβ-mediated ER stress, " PLoS ONE, vol. 5, no. 5, Article ID e10489, 2010.
173. Y. Inokuchi, Y. Nakajima, M. Shimazawa et al. , "Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death, " Investigative Ophthalmology & Visual Science, vol. 50, no. 1, pp. 334-344, 2009.
174. K. Takano, Y. Kitao, Y. Tabata et al. , "A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress, " American Journal of Physiology-Cell Physiology, vol. 293, no. 6, pp. C1884-C1894, 2007.
175. I. Yoshida, A. Monji, K.-I. Tashiro, K.-I. Nakamura, R. Inoue, and S. Kanba, "Depletion of intracellularCa2+ store itselfmay be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells, " Neurochemistry International, vol. 48, no. 8, pp. 696-702, 2006.
176. H. Miura, K. Takano, Y. Kitao et al. , "A carbazole derivative protects cells against endoplasmic reticulum (ER) stress and glutathione depletion, " Journal of Pharmacological Sciences, vol. 108, no. 2, pp. 164-171, 2008.
177. E. Kojro, P. Fuger, C. Prinzen et al. , "Statins and the squalene synthase inhibitor zaragozic acid stimulate the nonamyloidogenic pathway by suppression of cholesterol synthesis, " Journal of Alzheimers Disease, vol. 20, pp. 1215-1231, 2010.
178. G. Marwarha, B. Dasari, and O. Ghribi, "Endoplasmic reticulum stress-induced CHOP activation mediates the downregulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol, " Cellular Signalling, vol. 24, no. 2, pp. 484-492, 2012.
179. H. Wang, A. Megill, K. He, A. Kirkwood, andH.-K. Lee, "Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity, " Neural Plasticity, vol. 2012, Article ID272374, 24 pages, 2012.